GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Total Equity

Philogen SpA (STU:78Q) Total Equity : €138.66 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA Total Equity?

Philogen SpA's total equity for the quarter that ended in Dec. 2024 was €138.66 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Philogen SpA Total Equity Historical Data

The historical data trend for Philogen SpA's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA Total Equity Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
55.67 105.09 97.92 90.59 138.66

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.92 104.84 90.59 75.83 138.66

Philogen SpA Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Philogen SpA's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=168.452-29.795
=138.66

Philogen SpA's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=168.452-29.795
=138.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Philogen SpA Total Equity Related Terms

Thank you for viewing the detailed overview of Philogen SpA's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (STU:78Q) » Definitions » Total Equity
Comparable Companies
MIL:UBM MIL:ARBS VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX XKRX:196170 OCSE:GMAB MRNA
Traded in Other Exchanges
PHIL:Italy 78Q:Germany
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Website
https://www.philogen.com
Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.

Philogen SpA Headlines

No Headlines